dihydroxyphenylalanine has been researched along with Insulinoma in 11 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "(18)F-fluorodihydroxyphenylalanine (FDOPA) PET seems to be of limited value to localize pancreatic insulin-secreting tumors in adult with hyperinsulinemic hypoglycemia." | 7.81 | Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia. ( Bachellier, P; Bahougne, T; Goichot, B; Imperiale, A; Namer, IJ; Taïeb, D, 2015) |
| "A 65-year-old woman with suspected insulinoma on the basis of clinical, biochemical, and conventional imaging data underwent F-dihydroxyphenylalanine (DOPA) PET/CT and Ga-DOTANOC PET/CT." | 7.79 | A case of insulinoma detected by (68)Ga-DOTANOC PET/CT and missed by (18)F-dihydroxyphenylalanine PET/CT. ( Agnes, S; Campanini, N; Giordano, A; Inzani, F; Rindi, G; Rufini, V; Treglia, G, 2013) |
| "(18)F-fluorodihydroxyphenylalanine (FDOPA) PET seems to be of limited value to localize pancreatic insulin-secreting tumors in adult with hyperinsulinemic hypoglycemia." | 3.81 | Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia. ( Bachellier, P; Bahougne, T; Goichot, B; Imperiale, A; Namer, IJ; Taïeb, D, 2015) |
| "A 65-year-old woman with suspected insulinoma on the basis of clinical, biochemical, and conventional imaging data underwent F-dihydroxyphenylalanine (DOPA) PET/CT and Ga-DOTANOC PET/CT." | 3.79 | A case of insulinoma detected by (68)Ga-DOTANOC PET/CT and missed by (18)F-dihydroxyphenylalanine PET/CT. ( Agnes, S; Campanini, N; Giordano, A; Inzani, F; Rindi, G; Rufini, V; Treglia, G, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakuz, TS | 1 |
| Berger, E | 1 |
| El-Rabadi, K | 1 |
| Wadsak, W | 1 |
| Haug, A | 1 |
| Hacker, M | 1 |
| Karanikas, G | 1 |
| Cuccurullo, V | 1 |
| Di Stasio, GD | 1 |
| Mansi, L | 1 |
| Sood, A | 1 |
| Basher, RK | 1 |
| Kang, M | 1 |
| Shukla, J | 1 |
| Behera, A | 1 |
| Walia, R | 1 |
| Nada, R | 1 |
| Mittal, BR | 1 |
| Bhattacharya, A | 1 |
| Taieb, D | 4 |
| Legmann, P | 1 |
| Prat, F | 1 |
| Chevallier, P | 1 |
| Tenenbaum, F | 1 |
| Imperiale, A | 3 |
| Sebag, F | 2 |
| Vix, M | 1 |
| Castinetti, F | 1 |
| Kessler, L | 2 |
| Moreau, F | 1 |
| Bachellier, P | 2 |
| Guillet, B | 1 |
| Namer, IJ | 3 |
| Mundler, O | 2 |
| Bahougne, T | 1 |
| Goichot, B | 1 |
| Detour, J | 1 |
| Pierre, A | 1 |
| Boisson, F | 1 |
| Kreutter, G | 1 |
| Lavaux, T | 1 |
| Brasse, D | 1 |
| Marchand, P | 1 |
| Kauhanen, S | 2 |
| Seppänen, M | 2 |
| Nuutila, P | 2 |
| Tessonnier, L | 1 |
| Ghander, C | 1 |
| De Micco, C | 1 |
| Reynaud, R | 1 |
| Palazzo, FF | 1 |
| Conte-Devolx, B | 1 |
| Henry, JF | 1 |
| Treglia, G | 1 |
| Inzani, F | 1 |
| Campanini, N | 1 |
| Rindi, G | 1 |
| Agnes, S | 1 |
| Giordano, A | 1 |
| Rufini, V | 1 |
| Minn, H | 1 |
| Gullichsen, R | 1 |
| Salonen, A | 1 |
| Alanen, K | 1 |
| Parkkola, R | 1 |
| Solin, O | 1 |
| Bergman, J | 1 |
| Sane, T | 1 |
| Salmi, J | 1 |
| Välimäki, M | 1 |
1 review available for dihydroxyphenylalanine and Insulinoma
| Article | Year |
|---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Pe | 2019 |
10 other studies available for dihydroxyphenylalanine and Insulinoma
| Article | Year |
|---|---|
Clinical Value of
Topics: Adult; Aged; Aged, 80 and over; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyph | 2018 |
68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Magnetic Resonance Imaging; Multimodal Im | 2019 |
Topographic diagnosis: respective roles of morphological and functional imaging.
Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeo | 2013 |
18F-FDOPA PET/CT imaging of insulinoma revisited.
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; | 2015 |
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; | 2015 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; | 2017 |
Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography.
Topics: Carbidopa; Diagnostic Errors; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Hum | 2008 |
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Topics: Adolescent; Adult; Aged; Child; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemi | 2010 |
A case of insulinoma detected by (68)Ga-DOTANOC PET/CT and missed by (18)F-dihydroxyphenylalanine PET/CT.
Topics: Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Insulinoma; Multimodal Imaging | 2013 |
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Insulin-Secreting Cells; Insulinoma; Mal | 2007 |